Literature DB >> 10942140

Quantitative analysis of eotaxin and RANTES messenger RNA in nasal polyps: association of tissue and nasal eosinophils.

S H Shin1, J Y Park, C H Jeon, J K Choi, S H Lee.   

Abstract

OBJECTIVES/HYPOTHESIS: Nasal polyps develop in the ethmoidal and middle turbinate area, often in relation to inflammatory conditions. Their exact etiology and pathogenesis are still under debate. Histologically, the polyps are infiltrated by a number of inflammatory cells, with eosinophil predominating in most specimens. This finding suggests that the nasal polyp is an inflammatory growth that is controlled by the local environment. The chemokines eotaxin and RANTES (regulated on activation normal T cell expressed and secreted) have been postulated to be involved in the recruitment and activation of eosinophils to certain inflamed tissues. The purpose of this study was to investigate eotaxin and RANTES mRNA expression in nasal polyps and its effect on tissue and nasal eosinophils.
METHODS: Nasal polyps (917 allergic and 30 nonallergic cases) were obtained from endoscopic sinus surgery, and 15 normal inferior turbinates also were taken. Immunohistochemical staining for eosinophils and quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) tests for eotaxin and RANTES mRNA expression were performed, and the concentration of nasal eosinophil cationic protein (ECP) was measured.
RESULTS: The amounts of eotaxin mRNA in the allergic nasal polyps were 11.4 times higher and the levels in the nonallergic polyps were 6.4 times higher than in the normal inferior turbinate. However, the RANTES mRNA expression did not show any differences among the three groups. Tissue eosinophilia and nasal ECP levels were significantly correlated with eotaxin mRNA level but not with RANTES mRNA expression.
CONCLUSION: Nasal polyp eosinophilic infiltration and activation correlate mainly with increased eotaxin gene expression rather than with RANTES expression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10942140     DOI: 10.1097/00005537-200008000-00025

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  8 in total

1.  Plasma RANTES and eotaxin levels are correlated with the severity of chronic rhinosinusitis.

Authors:  Pin-Zhir Chao; Chi-Ming Chou; Chen-Ho Chen
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-01-24       Impact factor: 2.503

Review 2.  Functions of Exosomes and Microbial Extracellular Vesicles in Allergy and Contact and Delayed-Type Hypersensitivity.

Authors:  Katarzyna Nazimek; Krzysztof Bryniarski; Philip W Askenase
Journal:  Int Arch Allergy Immunol       Date:  2016-11-08       Impact factor: 2.749

Review 3.  Mediators in nasal polyposis.

Authors:  Claus Bachert; Philippe Gevaert; Gabriele Holtappels; Paul van Cauwenberge
Journal:  Curr Allergy Asthma Rep       Date:  2002-11       Impact factor: 4.806

4.  Eosinophil Chemokines and Clara Cell Protein 16 Production in Nasal Mucosa of Patients with Persistent Allergic Rhinitis.

Authors:  Aleksandar Perić; Cveta Špadijer Mirković; Biserka Vukomanović Đurđević; Aneta V Perić; Danilo Vojvodić
Journal:  Eurasian J Med       Date:  2017-10

5.  Wogonin attenuates nasal polyp formation by inducing eosinophil apoptosis through HIF-1α and survivin suppression.

Authors:  Roza Khalmuratova; Mingyu Lee; Ji-Hun Mo; YunJae Jung; Jong-Wan Park; Hyun-Woo Shin
Journal:  Sci Rep       Date:  2018-04-18       Impact factor: 4.379

6.  Changes in inflammatory biomarkers in the nasal mucosal secretion after septoplasty.

Authors:  Marn Joon Park; Yong Ju Jang
Journal:  Sci Rep       Date:  2022-09-28       Impact factor: 4.996

7.  Significance of susceptible gene expression profiles in nasal polyposis.

Authors:  De Yun Wang
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-12-26       Impact factor: 3.372

8.  In vitro effect of glucocorticoids on nasal polyps.

Authors:  Fabiana Valera; María S Brassesco; Angel M Castro-Gamero; Maria A Cortez; Rosane G P Queiroz; Luiz G Tone; Wilma T Anselmo-Lima
Journal:  Braz J Otorhinolaryngol       Date:  2011 Sep-Oct
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.